Inhaled Insulin, Associated with Lung Cancer?
April 11, 2008 by Gloria Gamat
Filed under Diseases & Conditions
Inhaled insulin (Pfizer’s Exubera) may be associated with lung cancer.
Such were the findings revealed by a clinical trial, in turn prompting Pfizer to update its product labeling.
The data demonstrate that six of 4,740 patients treated with the inhaled powder form of recombinant human insulin (Exubera, Pfizer) developed lung cancer, compared with one of 4,292 patients not treated with the therapy. One inhaled insulin-treated patient also reported primary lung malignancy in a post-marketing report.
Though unrelated to this new date, Pfizer apparently will stop the marketing of Exubera in October.
Hmmm…could really be unrelated?
Read more from Endocrine Today.
